This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Rite Aid Dividend

Dividend criteria checks 0/6

Rite Aid does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield	1.2%
Next dividend pay date	n/a
Ex dividend date	n/a
Dividend per share	n/a
Earnings per share	-US$29.90
Future Dividend Yield	0%

Recent dividend updates

No updates

Recent updates

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if RADC.Q's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if RADC.Q's dividend payments have been increasing.

Dividend Yield vs Market

Rite Aid Dividend Yield vs Market

How does RADC.Q dividend yield compare to the market?
Segment	Dividend Yield
Company (RADC.Q)	n/a
Market Bottom 25% (US)	1.5%
Market Top 25% (US)	4.6%
Industry Average (Consumer Retailing)	1.2%
Analyst forecast (RADC.Q) (up to 3 years)	0%

Notable Dividend: Unable to evaluate RADC.Q's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate RADC.Q's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate RADC.Q's payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as RADC.Q has not reported any payouts.

This company listing is no longer active

Rite Aid Dividend

Dividend criteria checks 0/6

Key information

Recent dividend updates

Recent updates

Rite Aid Corporation Announces Resignation of Jeffrey S. Stein, as Chief Restructuring Officer

Rite Aid Announces Availability of Opill At All Locations

Motion for Asset Sale Approved for Rite Aid Corporation

Second Amended Reorganization Plan & Dsiclosure Statement Filed by Rite Aid Corporation

Rite Aid Corporation (OTCPK:RADC.Q) acquired Tuttles Pharmacy Inc from Pellegrini family.

Rite Aid Corporation announced delayed 10-Q filing

Robbins Geller Rudman & Dowd LLP Announces Proposed Settlement in the Rite Aid Corporation Securities Litigation

Rite Aid Corporation Announces Board Appointments

Rite Aid Corporation(OTCPK:RADC.Q) dropped from S&P TMI Index

Rite Aid Corporation(OTCPK:RADC.Q) dropped from S&P Global BMI Index

NYSE Suspends Trading in Rite Aid

Rite Aid Corporation Filed for Bankruptcy

Rite Aid Shareholders Are Wiped Out Under A Chapter 11 Bankruptcy Plan

Rite Aid Corporation Filed for Bankruptcy

Rite Aid Corporation announced delayed 10-Q filing

Rite Aid Corporation Receives Written Notice from the New York Stock Exchange

Rite Aid Corporation is Heading Towards Bankruptcy

Rite Aid and Bartell Drugs Announce Availability of Appointments for Updated COVID-19 Vaccine

Rite Aid Announces Availability of OTC NARCAN Nasal Spray At All Locations

Rite Aid Corporation Announces Availability of Flu and RSV Vaccine Appointments at All Locations

New minor risk - Share price stability

Rite Aid Corporation Announces Executive Changes

Rite Aid Corporation, Annual General Meeting, Jul 26, 2023

Rite Aid May Be Forced Into Ch.11 Bankruptcy To Resolve Opioid Liabilities

Consensus EPS estimates fall by 52%, revenue upgraded

New minor risk - Shareholder dilution

Rite Aid Corporation, Annual General Meeting, Aug 18, 2023

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Rite Aid Q1 Earnings Preview: Bears Remain In Control

Rite Aid Corporation(NYSE:RAD) dropped from Russell Small Cap Comp Growth Index

Rite Aid Corporation to Report Q1, 2024 Results on Jun 29, 2023

Rite Aid Corporation Names Thomas Sabatino Chief Legal Officer

Rite Aid Announces Launch of RYSHI Beauty and Personal Care Essentials

Elixir Announces the Next Wave of Innovation for Pharmacy Benefits Technology Platform

Consensus EPS estimates fall by 67%, revenue upgraded

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target decreased by 22% to US$3.00

Department of Justice Intervenes in Baron & Budd Whistleblower Lawsuit Against Rite Aid

Rite Aid Corporation Announces Departure of Heyward Donigan as President and as A Member of the Board

Rite Aid names interim CEO as Heyward Donigan departs

Price target decreased to US$3.67

Price target decreased to US$3.83

Rite Aid Corporation Provides Earnings Guidance for the Fiscal Year 2023

Rite Aid Q3 2023 Earnings Preview

Rite Aid Corporation to Report Q3, 2023 Results on Dec 21, 2022

Bronstein, Gewirtz & Grossman, LLC Notifies Rite Aid Corporation (RAD) Investors of Class Action and Encourages Investors to Actively Participate

Insufficient new directors

Rite Aid spikes 20% on above average volume

Bronstein, Gewirtz & Grossman, LLC Files Lawsuit Against Rite Aid Corporation and Certain of Its Officers

Rite Aid Corporation Investors with Substantial Losses Have Opportunity to Lead the Rite Aid Class Action Lawsuit

Rite Aid partners with Google Cloud on pharmacy insights, customer engagement

Second quarter 2023 earnings: EPS misses analyst expectations

Rite Aid Corporation Announces Impairment Charges for the Second Quarter Ended August 27, 2022

Stability and Growth of Payments

Dividend Yield vs Market

Earnings Payout to Shareholders

Cash Payout to Shareholders

Discover strong dividend paying companies